)
Century Therapeutics (IPSC) investor relations material
Century Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
The 2026 Annual Meeting will be held virtually on June 11, 2026, with voting on key proposals including director elections, auditor ratification, and a charter amendment to increase authorized shares.
Recent highlights include the advancement of clinical programs (CNTY-813, CNTY-308, CNTY-101), new board appointments, and a $135 million private placement led by TCGX and other major investors.
Voting matters and shareholder proposals
Stockholders will vote on: (1) election of two Class II directors for terms expiring in 2029, (2) ratification of Ernst & Young LLP as independent auditor for 2026, (3) approval to increase authorized common stock from 300M to 450M shares, and (4) adjournment if insufficient votes are present.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board will reduce from seven to six members after the meeting; two Class II nominees are Alessandro Riva, M.D. and Han Lee, Ph.D., M.B.A.
Board committees (Audit, Compensation, Nominating & Corporate Governance) are composed entirely of independent directors.
Lead Independent Director role is separated from the Chair/CEO; annual board and committee self-evaluations are conducted.
Board diversity, independence, and skills matrix are emphasized in director selection.
- Lead cell therapy programs advanced, net loss narrowed, and cash runway extended into 2029.IPSC
Q4 202512 Mar 2026 - Pivot to iPSC-derived beta islet therapy for type 1 diabetes, IND in late 2025, data in 2027.IPSC
Leerink Global Healthcare Conference 202610 Mar 2026 - Lead cell therapy programs targeting diabetes and autoimmune diseases advance toward clinical trials.IPSC
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Raised $135M to advance iPSC cell therapies; registration enables resale of 176M shares.IPSC
Registration Filing5 Feb 2026 - iPSC cell therapies show strong safety, efficacy, and promise for autoimmune and oncology.IPSC
Guggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026 - Promising clinical and preclinical progress, platform advances, and strong partnerships drive outlook.IPSC
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026 - Shelf registration allows flexible capital raising with strong management and indemnification.IPSC
Registration Filing5 Jan 2026 - Registering 7.87M shares for resale post-acquisition; no proceeds to company, Nasdaq: IPSC.IPSC
Registration Filing16 Dec 2025 - Biotech seeks $200M to advance allogeneic iPSC cell therapies for autoimmune diseases and cancer.IPSC
Registration Filing16 Dec 2025
Next Century Therapeutics earnings date
Next Century Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage